HCA Earnings
Upcoming earnings date and last 8 quarters of EPS surprise.
Next Earnings
EPS Surprise — Last 8 Quarters
Quarterly Detail
| Quarter | Report Date | Est EPS | Actual EPS | Surprise % | Result |
|---|---|---|---|---|---|
| Q1 2026 | Apr 24, 2026 | 7.13 | 7.15 | +0.29% | Inline |
| Q4 2025 | Jan 27, 2026 | 7.48 | 8.01 | +7.14% | Beat |
| Q3 2025 | Oct 24, 2025 | 5.73 | 6.96 | +21.55% | Beat |
| Q2 2025 | Jul 25, 2025 | 6.32 | 6.84 | +8.21% | Beat |
| Q1 2025 | Apr 25, 2025 | 5.75 | 6.45 | +12.09% | Beat |
| Q4 2024 | Jan 24, 2025 | 6.14 | 6.22 | +1.22% | Beat |
| Q3 2024 | Oct 25, 2024 | 4.98 | 4.88 | -2.10% | Miss |
| Q2 2024 | Jul 23, 2024 | 4.93 | 5.50 | +11.58% | Beat |
Recent Guidance Mentions (8-K)
- Apr 30, 2026 · 8-K
e Exchange Act) or presentation of market-related or statistical data contained in any of the Registration Statement, the Disclosure Package and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. (aa) Except as set forth in or contemplated in each of the Registration Statement, the Disclosure P
View 8-K filing → - Apr 30, 2026 · 8-K
Regions Securities LLC Scotia Capital (USA) Inc. TD Securities (USA) LLC Settlement Date April 30, 2026 (T+3) We expect that delivery of the notes will be made to investors on or about April 30, 2026, which will be the third business day following the date of this pricing term sheet (such settl
View 8-K filing → - Apr 24, 2026 · 8-K
These unfavorable volume impacts were mostly offset by the recognition of certain Medicaid supplemental programs that were not included in the Company's initial 2026 guidance. Balance Sheet and Cash Flows from Operations As of March 31, 2026, HCA Healthcare, Inc.’s balance sheet reflected cash and cash equivalents of $940 million, total debt of $48.
View 8-K filing → - Apr 24, 2026 · 8-K
Future dividends are expected to be funded by cash balances and future cash flows from operations. 2026 Guidance Today, the Company is reaffirming its 2026 estimated guidance ranges previously issued on January 27, 2026. The Company’s guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding vol
View 8-K filing → - Apr 24, 2026 · 8-K
A table reconciling forecasted net income attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release. 2 The Company’s guidance is based on current plans and expectations and are subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-L
View 8-K filing → - Feb 25, 2026 · 8-K
ny to a Participant as determined by the Committee in its sole discretion, but only to the extent such offset complies with the requirements of Section 409A of the Code and the guidance issued thereunder. If any restatement of the Company’s financial results indicates that the Company should have made higher performance-based payments than those actually made
View 8-K filing →
Data updated May 25, 2026 · source: Yahoo Finance via yfinance